Skip to main content
SpringerLink
Log in

Dizziness produced by a potent 5HT1A receptor agonist (eptapirone) is not due to postural hypotension

  • Letter to the Editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Coupland NJ, Bailey JE, Wilson SJ, Horvath R, Nutt DJ (1995a) The effects of clonidine on cardiovascular responses to standing in healthy volunteers. Clinic Auton Res 5:171–177

    Google Scholar 

  • Coupland NJ, Wilson SJ, Potokar J, Bell CE, Bailey JE, Nutt DJ (1995b) A comparison of the effects of phenelzine treatment with moclobemide treatment on cardiovascular reflexes. Int Clin Psychopharmacol 10:229–238

    Google Scholar 

  • Coupland NJ, Bell CJ, Potokar JP (1996) Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 16(5):356–362

    Article  Google Scholar 

  • De Bruyn S, Tournoux A, Deprez D, Pezous N, Lafon M (2002) Study of the tolerability, pharmacodynamics and pharmacokinetics of F 11440 administered in repeated doses for 14 days Pierre Fabre internal report No L0068 GE 101

  • Driver HS, Flanigan MJ, Bentley AJ, Luus HG, Shapiro CM, Mitchell D (1995) The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects. Psychopharmacology (Berl) 117(2):186–192

    Google Scholar 

  • Koek W, Patoiseau JF, Assie MB, Cosi C, Kleven MS, Dupont-Passelaigue E, Carilla-Durand E, Palmier C, Valentin JP, John G, Pauwels PJ, Tarayre JP, Colpaert FC (1998) F11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential. J Pharmacol Exp Ther 287:266–283

    Google Scholar 

  • Robinson DS, Sitsen JM, Gibertini M (2003) A review of the efficacy and tolerability of immediate-release and extended-release formulations of gepirone. Clin Ther 25(6):1618–1633

    Article  Google Scholar 

  • Sramek JJ, Hong WW, Hamid S, Nape B, Cutler NR (1999) Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxiety. Depress Anxiety 9(3):131–134

    Google Scholar 

  • van der Post J, Schram MT, Schoemaker RC, Pieters MS, Fuseau E, Pereira A, Baggen S, Cohen AF, van Gerven JM (2002) CNS effects of sumatriptan and rizatriptan in healthy female volunteers. Cephalalgia 22(4):271–281

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychopharmacology Unit, University of Bristol, Dorothy Hodgkin Building, Whitson St, Bristol, BS1 3NY, UK

    S. J. Wilson, J. E. Bailey & D. J. Nutt

Authors
  1. S. J. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. E. Bailey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. J. Nutt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. J. Wilson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilson, S.J., Bailey, J.E. & Nutt, D.J. Dizziness produced by a potent 5HT1A receptor agonist (eptapirone) is not due to postural hypotension. Psychopharmacology 179, 895–896 (2005). https://doi.org/10.1007/s00213-004-2111-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-004-2111-4

Keywords

Search

Navigation